Nociceptin/orphanin FQ: Role in nociceptive information processing

Progress in Neurobiology

Volumn 57, Issue 5, 1999, Pages 527-535

  Yamamoto, Tatsuo ^a   Nozaki Taguchi, Natsuko ^a   Sakashita, Yoshihiko ^a   Kimura, Sadao ^a  

^a CHIBA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DYNORPHIN A; NOCICEPTIN; OPIATE RECEPTOR;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ELECTROPHYSIOLOGY; INFORMATION PROCESSING; MOUSE; NEUROTRANSMISSION; NOCICEPTION; NONHUMAN; PAIN; PAIN THRESHOLD; PERIPHERAL NERVE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; REVIEW; SIGNAL TRANSDUCTION;

ANALGESIA; ANIMALS; HUMANS; MICE; OPIOID PEPTIDES; PAIN; PAIN THRESHOLD; RECEPTORS, OPIOID; SPINAL CORD; TRANSCRIPTION, GENETIC;

EID: 0033018872     PISSN: 03010082     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-0082(98)00067-7     Document Type: Review

References (89)

1. Abdulla F. A., Smith P. A. Nociceptin inhibits T-type Ca2+ channel current in rat sensoty neurons by a G-protein-independent mechanism. J. Neurosci. 14:1997;8721-8728.
2. Andoh T., Itoh M., Kuraishi Y. Nociceptin gene expression in rat dorsal root ganglia induced by peripheral inflammation. NeuroReport. 8:1997;2793-2796.
3. Berzetei-Gurske I. P., Schwartz R. W., Toll L. Determination of activity for nociceptin in the mouse vas deferens. Eur. J. Pharmac. 302:1996;R1-R2.
4. Bunzow J. R., Saez C., Mortrud M., Bouvier C., Williams J. T., Low M., Grandy D. K. Molecular cloning and tissue distribution of a putativce member of the rat opioid receptor gene family that is not a μ, δ and κ opioid receptor type. FEBS Lett. 347:1994;284-288.
5. Calo G., Rizzi A., Bogoni G., Neugebauer V., Salvadori S., Guerrini R., Bianchi C., Regoli D. The mouse vas deferens: a pharmacological preparation sensitive to nociceptin. Eur. J. Pharmac. 311:1996;R3-R5.
6. Calo G., Rizzi A., Bodin M., Neugebauer W., Salvadori S., Guerrini R., Bianchi C., Regoli D. Pharmacological characterizatio of nociceptin receptor: an in vitro study. Can. J. Physiol. Pharmac. 75:1997;713-718.
7. Chen Y., Fan Y., Liu J., Mestek A., Tian M., Kozak C. A., Yu L. Molecular cloning, tissue distribution and chromosomal localization of a novel member of the opioid receptor gene family. FEBS Lett. 347:1994;279-283.
8. Cheng Z. J., Fan G. H., Zhao J., Wu Y. L., Jiang L. Z., Zhu Y., Pei G., Ma L. Endogenous opioid receptor-like receptor in human neuroblastoma SK-N-SH cells: activation of inhibitory G protein and homologous desensitization. Neuroreport. 8:1997;1913-1918.
9. Connor M., Vaughan C. W., Chieng B., Christie M. J. Nociceptin receptor coupling to a potassium conductance in rat locus coeruleus neuones in vitro. Br. J. Pharmac. 119:1996;1614-1618.
10. Connor M., Yeo A., Henderson G. The effect of nociceptin on CA2+ channel current and intracellular Ca2+ in the SH-SY5Y human neuroblastoma cell line. Br. J. Pharmac. 118:1996;205-207.
11. Dawson-Basoa M., Gintzler A. R. Nociceptin (Orphanin FQ) abolishes gestational and ovarian sex steroid-induced antinociceptin and induces hyperalgesia. Brain Res. 750:1997;48-52.
12. Dickenson A. H., Sullivan A. F. Evidence for a role of the NDMA receptor in the frequency dependent potentiation of deep rat dorsal horn nociceptive neurones following C fiber stimulation. Neuropharmacology. 26:1987;1235-1238.
13. Dickenson A. H., Sullivan A. F. Differential effects of excitatory amino acid antagonists on dorsal horn nociceptive neurones in the rat. Brain Res. 506:1990;31-39.
14. Dun N. J., Dun S. L., Hwang L. L. Nociceptin-like immunoreactivity in autonomic nuclei of the rat spinal cord. Neurosci. Lett. 234:1977;95-98.
15. Dunnill R. J., kakizawa K., McKnight A. T., Henderson G. Characterization of the actions of naloxone benzoylhydrazone at μ-opioid, κ-opioid and ORL1 receptors in isolated tissues from rat and guinea-pig. Br. J. Pharmac. 119:1996;275P.
16. Erb K., Liebel J. T., Tegeder I., Zeilhofer H. U., Brune K., Geisslinger G. Spinally delivered nociceptin/orphanin FQ reduces flinching behaviour in the rat formalin test. NeuroReport. 8:1997;1967-1970.
17. Faber E. S., Chambers J. P., Evans R. H., Henderson G. Depression of glutamatergic transmission by nociceptin in the neonatal rat hemisected spinal cord preparation in vitro. Br. J. Pharmac. 119:1996;189-190.
18. Fawzi A. B., Zhang H., Weig B., Hawes B., Graziano M. P. Nociceptin activation of the human ORL1 receptor expression in Chinese hamster ovary cells: functional homology with opioid receptors. Eur. J. Pharmac. 336:1997;233-242.
19. 3H]nociceptin binding sites from telencephalic to mesencephalic regions of the mouse brain. Neuosci. Lett. 230:1997;33-36.
20. Fukuda K., Kato S., Mori K., Nishi M., Takeshima H., Iwabe N., Miyata T., Houtani T., Sugimoto T. cDNA cloning and regional distribution of a novel member of the opioid receptor family. FEBS Lett. 343:1994;42-46.
21. Fukuda K., Shoda T., Morikawa H., Kato S., Mori K. Activation of mitogen-activated protein kinase by the nociceptin receptor expressed in Chinese hamster ovary cells. FEBS Lett. 412:1997;290-294.
22. Gintzler A. R., Adapa I. D., Toll L., Medina V. M., Wang L. Modulation of enkephalin release by nociceptin (orphanin FQ). Eur. J. Pharmac. 325:1997;29-34.
23. Giuliani S., Maggi C. A. Inhibition of tachykinin release from peripheral endings of sensory nerves by nociceptin, a novel opioid peptide. Br. J. Pharmac. 118:1996;1567-1569.
24. Grisel J. E., Mogil J. S., Belknap J. K., Grandy D. K. Orphanin FQ acts as a supraspinal, but not a spinal, anti-opioid peptide. NeuroReport. 7:1996;2125-2129.
25. Guerrini R., Calo G., Rizzi A., Bianchi C., Lazarus L. H., Salvadori S., Temussi P. A., Regoli D. Address and message sequences for the nociceptin receptor: a structure-activity study of nociceptin-(1-13)-peptide amide. J. Med. Chem. 40:1997;1789-1793.
26. Hao J. X., Wiesenfeld-Hallin Z., Xu X. J. Lack of cross-tolerance between the antinociceptive effect of intrathecal orphanin FQ and morphine in the rat. Neurosci. Lett. 223:1997;49-52.
27. Hara N., Minami T., Okuda-Ashitaka E., Sugimoto T., Sakai M., Onaka M., Mori H., Imanishi T., Shingu K., Ito S. Characterization of nociceptin hyperalgesia and allodynia in conscious mice. Br. J. Pharmac. 121:1997;401-408.
28. Heinricher M. M., McGaraughty S., Grandy D. K. Circuitry underlying antiopioid actions of orphanin FQ in the rostral ventromedial medulla. J. Neurphysiol. 78:1997;3351-3358.
29. Helyes Z., Nemeth J., Pinter E., Szolcsanyi J. Inhibition by nociceptin of neurogenic inflammation and the release of SP and CGRP from sensory nerve terminals. Br. J. Pharmac. 121:1997;613-615.
30. Henderson G., McKnight A. T. The orphan opioid receptor and its endogenous ligand-nociceptin/orphanin FQ. Trends Pharmac. Sci. 18:1997;293-300.
31. Houtani T., Nishi M., Takeshima H., Nukada T., Sugimoto T. Structure and regional distribution of nociceptin/orphanin FQ precursor. Biophys. Biochem. Res. Commun. 219:1996;714-719.
32. Ikeda K., Kobayashi K., Kobayashi T., Ichikawa T., Kumanishi T., Kishida H., Yano R., Manabe T. Functional coupling of the nociceptin/orphanin FQ receptor with the G-protein-activated K+ (GIRK) channel. Mol. Brain Res. 45:1997;117-126.
33. Kieffer B. L. Recent advances in molecular recognition and signal transduction of active peptides: receptors for opioid peptides. Cell Mol. Neurobiol. 15:1995;615-635.
34. King M. A., Rossi G. C., Chang A. H., Williams L., Pasternak G. W. Spinal analgesic activity of orphanin FQ/nociceptin and its fragments. Neurosci. Lett. 223:1997;113-116.
35. Knoflach F., Reinscheid R. K., Civelli O., Kemp J. A. Modulation of voltate-gated calcium channels by orphanin FQ in freshly dissociated hippocampal neurons. J. Neurosci. 16:1996;6657-6664.
36. Kobayashi T., Ikeda K., Togashi S., Itoh N., Kumanishi T. Effects of σ ligands on the nociceptin/orphanin FQ receptor co-expressed with the G-protein-activated K+ channel in Xenopus oocytes. Br. J. Pharmac. 120:1997;986-987.
37. Kummer W., Fischer A. Nociceptin and its receptor in guinea-pig sympathetic ganglia. Neurosci. Lett. 234:1997;35-38.
38. Lachowicz J. E., Shen Y., Monsma F. J. Jr., Sibley D. R. Molecular cloning of a novel G protein-coupled receptor related to the opiate receptor family. J. Neurochem. 64:1995;34-40.
39. Lai C. C., Wu S. Y., Dun S. L., Dun M. J. Nociceptin-like immunoreactivity in the rat dorsal horn and inhibition of substantia gelatinosa neurons. Neuroscience. 81:1997;887-891.
40. Liebel J. T., Swandulla D., Zeiohofer H. U. Modulation of excitatory synaptic transmission by nociceptin superficial dorsal horn neurones of the neonatal rat spinal cord. Br. J. Pharmac. 121:1997;425-432.
41. 2+ pathway. Biochem. Biophys. Res. Commun. 240:1997;304-308.
42. Ma L., Cheng Z. J., Fan G. H., Cai Y. C., Jiang L. Z., Pei G. Functional expression, activation and desensitization of opioid receptor-like receptor ORL1 in neuroblastoma x glioma NG108-15 hybrid cells. FEBS Lett. 403:1997;91-94.
43. Mathis J. P., Ryan-Moro J., Chang A., Hom J. S. H., Scheinberg D. A., Pasternak G. W. Biochemical evidence for orphanin FQ/nociceptin receptor heterogeneity in mouse brain. Biochem. Biophys. Res. Commun. 230:1996;462-465.
44. Matthes H., Seward E. P., Keiffer B., North R. A. Functional selectivity of orphinin FQ for its receptor coexpressed with potassium channel subunits in Xenopus laevis oocytes. Mol. Pharmac. 50:1996;447-450.
45. Mendel L. M. Physiological properties of numyelinated fiber projection to the spinal cord. Exp. Neurol. 16:1966;316-332.
46. Meunier J. C. Nociceptin/orphanin FQ and the opioid receptor-like ORL receptor. Eur. J. Pharmac. 340:1997;1-15.
47. Meunier J.-C., Mollereau C., Toll L., Suaudeau C., Moisand C., Alvinerie P., Butour J.-L., Guillemot J.-C., Ferrara P., Monsarrat B., Mazarguil H., Vassart G., Parmentier M., Costentin J. Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor. Nature. 377:1995;532-535.
48. Minami T., Okuda-Ashitaka E., Nishizawa M., Mori H., Ito S. Inhibition of nocicepti-induced allodynia in conscious mice by ptostaglandin D2. Br. J. Pharmac. 122:1997;605-610.
49. Mogil J. S., Grisel J. E., Reinscheid R. K., Civelli O., Belknap J. K., Grandy D. K. Orphanin FQ is a functional anti-opioid peptide. Neuroscience. 75:1996;333-337.
50. Mogil J. S., Grisel J. E., Zhangs G., Belknap J. K., Grandy D. K. Functional antagonism of mu-, delta- and kappa-opioid antinociception by orphanin FQ. Neurosci. Lett. 214:1996;131-134.
51. Mollereau C., Parmentier M., Mailleux P., Butour J.-L., Moisand C., Chalon P., Caput D., Vassart G., Meunier J.-C. ORL1, a novel member of the opioid receptor family: cloning, functional expression and localization. FEBS Lett. 341:1994;33-38.
52. Mollereau C., Simons M. J., Soularue P., Liners F., Vassart G., Meunier J. C., Parmentier M. Structure, tissue distribution, and chromosomal localization of the prepronociceptin gene. Proc. natl Acad. Sci. U.S.A. 93:1996;8666-8670.
53. Morgan M. M., Grisel J. E., Robbins C. S., Grandy D. K. Antinociception mediated by the periaqueductal gray is attenuated by orphanin FQ. NeuroReport. 8:1997;3431-3434.
54. Neal M. J., Cunningham J. R., Paterson S. J., McKnight A. T. Inhibition by nociceptin of the light-evoked release of Ach from retinal chlinergic neurones. Br. J. Pharmac. 120:1997;1399-1400.
55. Nicol B., Lambert D. G., Rowbotham D. J., Smart D., McKnight A. T. Nociceptin induced inhibition of K+ evoked glutamate release from rat cerebrocortical slices. Br. J. Pharmac. 119:1996;1081-1083.
56. Nishi M., Takeshima H., Mori M., Nakagawara K.-I., Takeuchi T. Structure and chromosomal mapping for the mouse κ-opioid receptor and an opioid receptor homologue (MOR-C). Biochem. Biophys. Res. Commun. 205:1994;1353-1357.
57. Nishi M., Houtani T., Noda Y., Mamiya T., Sato K., Doi T., Kuno J., Takeshima H., Nukada T., Nabeshima T., Yamashita T., Noda T., Sugimoto T. Unrestrained nociceptive response and disregulation of hearing ability in mice lacking the nociceptin/orphanin FQ receptor. EMBO J. 16:1997;1858-1864.
58. Nothacker H. P., Reinscheid R. K., Mansour A., Henningsen R. A., Ardati A., Monsma F. J. Jr., Watson S. J., Civelli O. Primary structure and tissue distribution of the orphanin FQ precursor. Proc. natl Acad. Sci. U.S.A. 93:1996;8677-8682.
59. Okuda-Ashitaka E., Tachibana S., Houtani T., Minami T., Masu Y., Nishi M., Takeshima H., Sugimoto T., Ito S. Identification and characterization of an endogenous ligand for opioid receptor homologue ROR-C: its involvement in allodynic response to innocuous stimulus. Mol. Brain Res. 43:1996;96-104.
60. Okuda-Ashitaka E., Minami T., Tachibana S., Yoshihara Y., Nishiuchi Y., Kimura T., Seiji T. Nocistatin, a peptide that blocks nociceptin action in pain transmission. Nature. 392:1998;286-289.
61. Patel H. J., Giembycz M. A., Spicuzza L., Barnes P. J., Belvisi M. G. Naloxone-insensitive inhibition of acetylcholine release from parasympathetic nerves innervating guinea-pig trachea by the novel opioid, nociceptin. Br. J. Pharmac. 120:1997;735-736.
62. Paul D., Levison J. A., Howard D. H., Pick C. G., Hahn E. F., Pasternak G. W. Naloxone benzoylhydrazone (NalBzoH) analgesia. J. Pharmac. Exp. Ther. 255:1990;769-774.
63. Pei G., Ling K., Pu L., Cunningham M. D., Ma L. Nociceptin/orphanin FQ stimulates extracellular acidification and desensitization of the response involves protein kinase C. FEBS Lett. 412:1997;253-256.
64. Reinscheid R. K., Nothacker H.-P., Bourson A., Ardati A., Henningsen R. A., Bunzow J. R., Grandy D. K., Langen H., Monsma F. J. Jr., Civelli O. Orphanin FQ: a neuropeptide that activates an opioidlike G protein-coupled receptor. Science. 270:1995;792-794.
65. Reisine T., Bell G. I. Molecular biology of opioid receptors. TiNS. 16:1993;506-510.
66. Riedl M., Shuster S., Vulchanova L., Wang J., Loh H. H., Elde R. Orphanin FQ/nociceptin-immunoreactive nerve fibers parallel those containing endogenous opioids in rat spinal cord. NeuroReport. 7:1996;1369-1372.
67. Rossi G. C., Leventhal L., Bolan E., Pasternak G. W. Pharmacological characterization of orphanin FQ/nociceptin and its fragments. J. Pharmac. Exp. Ther. 282:1997;858-865.
68. Rossi G. C., Leventhal L., Pasternak G. W. Naloxone sensitive orphanin FQ-induced analgesia in mice. Eur. J. Pharmac. 311:1996;R7-R8.
69. Satoh M., Minami M. Molecular pharmacology of the opioid receptors. Pharmac. Ther. 68:1995;343-364.
70. Schuligoi R., Amann R., Angelgerger P., Peskar B. A. Determination of nociceptin-like immunoreactivity in the rat dorsal spinal cord. Neurosci. Lett. 224:1997;136-138.
71. Schulz S., Schreff M., Nuss D., Gramsch C., Hollt V. Nociceptin/orphanin FQ and opioid peptides show overlapping distribution but not co-localization in pain-mudulatory brain regions. NeuroReport. 7:1996;3021-3025.
72. 35S]GTPγS binding in comparison with opioid agonist-stimulated ones in brain regions of the mice. Neurosci. Lett. 237:1997;113-116.
73. Stanfa L. C., Chapman V., Kerr N., Dickenson A. H. Inhibitory action of nociceptin on spinal dorsal horn neurones of the rat, in vivo. Br. J. Pharmac. 118:1996;1875-1877.
74. Tian J. H., Xu W., Zhang W., Fang Y., Grisel J. E., Mogil J. S., Grandy D. K., Han J. S. Involvement of endogenous orphinin FQ in electroacupuncture-induced analgesia. NeuroReport. 8:1997;497-500.
75. Tian J. H., Fang Y., Mogil J. S., Grisel J. E., Grandy D. K., Han J. S. Bidirectional modulatory effect of orphanin FQ on morphine-induced analgesia: antagonism in brain and potentiation in spinal cord of the rat. Br. J. Pharmac. 120:1997;676-680.
76. Ueda H., Yamaguchi T., Tokuyama S., Inoue M., Nishi M., Takeshima H. Partial loss of tolerance liability to morphine analgesia in mice lacking the nociceptin receptor gene. Neurosci. Lett. 237:1997;136-138.
77. Vaughan C. W., Christie M. J. Increase by the ORL1 receptor (opioid receptor-like1) ligand, nociceptin, of inwardly rectifying K conductance in dorsal raphe nucleus neurones. Br. J. Pharmac. 117:1996;1609-1611.
78. Vaughan C. W., Ingram S. L., Christie M. J. Actions of the ORL1 receptor ligand nociceptin on membrane properties of rat periaqueductal gray neurons in vitro. J. Neurosci. 17:1997;996-1003.
79. Wang J. B., Johnson P. S., Imai Y., Persico A. M., Ozenberger B. A., Eppler C. M., Uhl G. R. cDNA cloning of an orphan opiate receptor gene family member and its splice variant. FEBS Lett. 348:1994;75-79.
80. Wang X. M., Zhang K. M., Mokha S. S. Nociceptin (orphanin FQ), an endogenous ligand for the ORL1 (opioid-receptor-like1) receptor; modulates responses of trigeminal neurons evoked by excitatory amino acids and somatosensory stimuli. J. Neurophysiol. 76:1996;3568-3572.
81. Wick M. J., Minnerath S. R., Lin X., Elde R., Law P.-Y., Loh H. H. Isolation of a novel cDNA encoding a putatibe membrane receptor with high homology to the cloned μ, δ and κ opioid receptors. Mol. Brain Res. 27:1994;37-44.
82. Wu Y. L., Pu L., Ling K., Zhao J., Cheng Z. J., Ma L., Pei G. Molecular characterization and functional expression of opioid receptor-like1 receptor. Cell Res. 7:1997;69-77.
83. Xu X. J., Hao J. X., Wiesenfeld-Hallin Z. Nociceptin or antinociceptin: potent antinociceptive effect of orphanin FQ/nociceptin in the rat. NeuroReport. 7:1996;2092-2094.
84. Yamamoto T., Nozaki-Taguchi N. Effects of intrathecally administered nociceptin, an opioid receptor-like1 receptor agonist, and N-methyl-D-aspartate receptor antagonists, on the thermal hyperalgesia induced by partial sciatic nerve injury in the rat. Anesthesiology. 87:1997;1145-1152.
85. Yamamoto T., Nozaki-Taguchi N., Kimura S. Effects of intrathecally administered nociceptin, an opioid receptor-like1 (ORL1) receptor agonist, on the thermal hyperalgesia induced by unilateral constriction injury to the sciatic nerve in the rat. Neurosci. Lett. 224:1997;107-110.
86. Yamamoto T., Nozaki-Taguchi N., Kimura S. Effects of intrathecally administered nociceptin, an opioid receptor-like1 (ORL1) receptor agonist, on the thermal hyperalgesia induced by carageenan injection into the rat paw. Brain Res. 754:1997;329-332.
87. Yamamoto T., Nozaki-Taguchi N., Kimura S. Analgesic effect of intrathecally administered nociceptin, an opioid receptor-likea receptor agonist, in the rat formalin test. Neuroscience. 81:1997;249-254.
88. Yu T. P., Fein J., Phan T., Evans C. J., Xie C. W. Orphanin FQ inhibits synaptic transmission and long-term potentiation in rat hippocampus. Hippocampus. 7:1997;88-94.
89. Zhu C. B., Cao X. D., Xu S. F., Wu G. C. Orphanin FQ potentiates formalin-induced pain behavior and antagonizes morphine analgesia in rats. Neurosci. Lett. 235:1997;37-40.